Adiponectin and its receptors: Partners contributing to the "vicious circle" leading to the metabolic syndrome?

Pharmacological Research

Volumn 53, Issue 6, 2006, Pages 478-481

  Vasseur, Francis ^a  

^a UNIV LILLE   (France)

Author keywords

Adiponectin; Genetics; Metabolic syndrome

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ADIPONECTIN; ADIPONECTIN RECEPTOR 1; ADIPONECTIN RECEPTOR 2; CYTOKINE;

ACDC GENE; ARTICLE; EXPERIMENTAL MODEL; GENE; GENETIC VARIABILITY; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENYLATE KINASE; ADIPONECTIN; ANIMALS; HUMANS; METABOLIC SYNDROME X; RECEPTORS, CELL SURFACE;

EID: 33646774997     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2006.03.013     Document Type: Article

References (46)

1. Vionnet N., et al. Genomewide search for type 2 diabetes-susceptibility genes in french whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24. Am J Hum Genet 67 6 (2000) 1470-1480
2. Kissebah A.H., et al. Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome. Proc Natl Acad Sci USA 97 26 (2000) 14478-14483
3. Scherer P.E., et al. A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270 45 (1995) 26746-26749
4. Hu E., Liang P., and Spiegelman B.M. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 271 18 (1996) 10697-10703
5. Maeda K., et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221 2 (1996) 286-289
6. Nakano Y., et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem (Tokyo) 120 4 (1996) 803-812
7. Saito K., et al. Organization of the gene for gelatin-binding protein (GBP28). Gene 229 1-2 (1999) 67-73
8. Arita Y., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 1 (1999) 79-83
9. Trujillo M.E., and Scherer P.E. Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med 257 2 (2005) 167-175
10. Okamoto Y., et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32 2 (2000) 47-50
11. Weyer C., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 5 (1930-) 5
12. Hara K., et al. Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51 2 (2002) 536-540
13. Vasseur F., et al. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians. Hum Mol Genet 11 21 (2002) 2607-2614
14. Vasseur F., et al. Hypoadiponectinemia and high risk for type 2 diabetes are associated with adiponectin encoding (ACDC) gene promoter variants in morbid obesity: evidence for a role for ACDC in diabesity. Diabetologia 48 5 (2005) 892-899
15. Menzaghi C., et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 51 7 (2002) 2306-2312
16. Stumvoll M., et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes. Diabetes 51 1 (2002) 37-41
17. Populaire C., et al. Does the -11377 promoter variant of APM1 gene contribute to the genetic risk for type 2 diabetes mellitus in Japanese families?. Diabetologia 46 3 (2003) 443-445
18. Pollin T.I., et al. Linkage of plasma adiponectin levels to 3q27 explained by association with variation in the APM1 gene. Diabetes 54 1 (2005) 268-274
19. Yang W.S., et al. Allele-specific differential expression of a common adiponectin gene polymorphism related to obesity. J Mol Med 81 7 (2003) 428-434
20. Ukkola O., et al. Mutations in the adiponectin gene in lean and obese subjects from the Swedish obese subjects cohort. Metabolism 52 7 (2003) 881-884
21. Qi L., et al. The +276 polymorphism of the APM1 gene, plasma adiponectin concentration, and cardiovascular risk in diabetic men. Diabetes 54 5 (2005) 1607-1610
22. Bacci S., et al. The +276 G/T single nucleotide polymorphism of the adiponectin gene is associated with coronary artery disease in type 2 diabetic patients. Diabetes Care 27 8 (2004) 2015-2020
23. Lacquemant C., et al. The adiponectin gene SNP+45 is associated with coronary artery disease in type 2 (non-insulin-dependent) diabetes mellitus. Diabet Med 21 7 (2004) 776-781
24. Zietz B., et al. Gly15Gly polymorphism within the human adipocyte-specific apM-1gene but not Tyr111His polymorphism is associated with higher levels of cholesterol and LDL-cholesterol in caucasian patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 109 6 (2001) 320-325
25. Maeda N., et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8 7 (2002) 731-737
26. Kubota N., et al. Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem 277 29 (2002) 25863-25866
27. Fruebis J., et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. PNAS 98 4 (2001) 2005-2010
28. Yamauchi T., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 11 (2002) 1288-1295
29. Waki H., et al. Impaired multimerization of human adiponectin mutants associated with diabetes. Molecular structure and multimer formation of adiponectin. J Biol Chem 278 41 (2003) 40352-40363
30. Andersson U., et al. AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem 279 13 (2004) 12005-12008
31. Yamauchi T., et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423 6941 (2003) 762-769
32. Stefan N., et al. Polymorphisms in the gene encoding adiponectin receptor 1 are associated with insulin resistance and high liver fat. Diabetologia (2005)
33. Damcott C.M., et al. Genetic variation in adiponectin receptor 1 and adiponectin receptor 2 is associated with type 2 diabetes in the Old Order Amish. Diabetes 54 7 (2005) 2245-2250
34. Tsuchida A., et al. Insulin/Foxo1 pathway regulates expression levels of adiponectin receptors and adiponectin sensitivity. J Biol Chem 279 29 (2004) 30817-30822
35. Dietze-Schroeder D., et al. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 54 7 (2005) 2003-2011
36. Korner A., et al. Adiponectin expression in humans is dependent on differentiation of adipocytes and down-regulated by humoral serum components of high molecular weight. Biochem Biophys Res Commun 337 2 (2005) 540-550
37. Maeda N., et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50 9 (2001) 2094-2099
38. Yang W.S., et al. Genetic epistasis of adiponectin and PPARgamma2 genotypes in modulation of insulin sensitivity: a family-based association study. Diabetologia 46 7 (2003) 977-983
39. Rasouli N., et al. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab 290 1 (2006) 42-46
40. Yamauchi T., et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7 8 (2001) 941-946
41. Diamond Jr. F.B., et al. Correlates of adiponectin and the leptin/adiponectin ratio in obese and non-obese children. J Pediatr Endocrinol Metab 17 8 (2004) 1069-1075
42. Stefan N., et al. Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans. Diabetes 51 6 (1884-) 8
43. Fumeron F., et al. Adiponectin gene polymorphisms and adiponectin levels are independently associated with the development of hyperglycemia during a 3-year period: the epidemiologic data on the insulin resistance syndrome prospective study. Diabetes 53 4 (2004) 1150-1157
44. Hanley A.J., et al. Adiponectin in a native Canadian population experiencing rapid epidemiological transition. Diabetes Care 26 12 (2003) 3219-3225
45. Chinetti G., et al. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem Biophys Res Commun 314 1 (2004) 151-158
46. Narasimhan M.L., et al. Osmotin is a homolog of mammalian adiponectin and controls apoptosis in yeast through a homolog of mammalian adiponectin receptor. Mol Cell 17 2 (2005) 171-180